Original cervical cytology and follow-up biopsy results in positive high risk human papillomavirus DNA tests with high-level results

Acta Cytologica

Volumn 52, Issue 5, 2008, Pages 557-562

  Yuan, Qin ^a,b   Wilbur, David C ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cervical cancer; Human papillomavirus; Screening

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL POPULATION; DNA SCREENING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 52249092600     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325597     Document Type: Article

References (26)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
2. Kjaer S, Hogdall E, Frederiksen K, Munk C, van den Brule A, Svare E, Meijer C, Lorincz A, Iftner T: The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 2006;66:10630-10636
3. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819
4. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J; New Technologies for Cervical Cancer Screening Working Group: Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: Results at recruitment for a randomised controlled trial. Lancet Oncol 2006;7:547-555
5. Tsai HT, Wu CH, Lai HL, Li RN, Tung YC, Chuang HY, Wu TN, Lin LJ, Ho CK, Liu HW, Wu MT: Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Biomarkers Prev 2005;14:2544-2549
6. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C, Saslow D: Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-309
7. Knoepp SM, Kuebler DL, Wilbur DC: Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: A cytologic/histologic review of 191 cases. Diagu Mol Pathol 2007;16:125-129
8. Dalstein V, Riethmuller D, Pretet J-L, Carval KLB, Sautiere J-L, Carbillet J-P, Kantelip B, Schaal J-P, Mougin C: Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 2003;106:396-403
9. Ordi J, Alonso I, Torne A, Esteve R, Sierra E, Campo E, Puig-Tintore LM: Human papillomavirus load in Hybrid Capture II assay: Does increasing the cutoff improve the test? Gynecol Oncol 2005;99:313-319
10. Ho C-M, Cheng W-F, Chu T-Y, Chen C-A, Chuang M-H, Chang S-F, Hsieh C-Y: Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix. Br J Cancer 2006;95:1384-1389
11. Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M: Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: Dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev 2003;12:1038-1044
12. Castle PE, Schiffman M, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Wacholder S, Lorincz AT: Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1311-1314
13. Ko V, Tambouret RH, Kuebler DL, Black-Schaffer WS, Wilbur DC: Human papillomavirus testing using Hybrid Capture II with SurePath collection: Initial evaluation and longitudinal data provide clinical validation for this method. Cancer Cytopathol 2006;108:468-474
14. Stoler MH: Testing for human papillomavirus: Data driven implications for cervical neoplasia management. Clin Lab Med 2003;23:569-583
15. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
16. Nayar R, Tabbara SO: Atypical squamous cells: Update on current concepts. Clin Lab Med 2003;23:605-632
17. Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Prétet JL, Birembaut P, Clavel C: HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 2007;121:2198-2204
18. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W: Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007;20:256-266
19. Cheung JLK, Lo KWK, Cheung T-H, Tang JW, Chan PKS: Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 2006;194:1706-1712
20. Snijders PJF, Hogewoning CJA, Hesselink AT, Berkhof J, Voorhorst FJ, Bleeker MCG, Meijer CJLM: Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31, and 33-positive women with normal cytology. Int J Cancer 2006;119:1102-1107
21. Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Marales J, Alfaro M, Burk RD: Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 2006;66:10112-10119
22. Carcopina X, Henry M, Benmoura D, Fallabregues AS, Richet H, Boubli L, Tamalet C: Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol 2006;78.1131-1140
23. Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M: Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV 16 positive women for high-grade cervical lesions. Gynecol Oncol 2007;106:549-557
24. Chan PKS, Cheung JLK, Cheung T-H, Lo KWK, Siu S-SN, Tang JW: Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia. J Infect Dis 2007;196:868-875
25. de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ: High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res 2007;13:132-138
26. Andersson S, Hansson B, Norman I, Gaberi V, Mints M, Hjerpe A, Karlsen F, Johansson B: Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a. Int J Oncol 2006;29:705-711